CN Stock MarketDetailed Quotes

300482 Guangzhou Wondfo Biotech

Watchlist
  • 24.60
  • -0.15-0.61%
Noon Break Dec 3 11:30 CST
11.84BMarket Cap22.61P/E (TTM)

Guangzhou Wondfo Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-63.95%264.16M
-62.27%393.56M
56.27%1.17B
-27.72%840.3M
226.30%732.82M
79.15%1.04B
27.88%749M
16.70%1.16B
-75.46%224.58M
-39.37%582.19M
Transactional financial assets
37.05%1.85B
35.92%1.45B
-21.28%1.01B
-22.99%722.45M
-9.30%1.35B
-19.33%1.06B
150.56%1.28B
63.79%938.07M
269.66%1.49B
109.12%1.32B
Notes receivable and accounts receivable
55.88%886.66M
40.50%826.87M
31.36%744.11M
10.89%599.87M
-10.82%568.8M
-7.21%588.51M
-72.47%566.47M
7.81%540.97M
18.74%637.79M
22.11%634.26M
-Notes receivable
69.98%2.58M
-86.55%391.16K
-90.32%195.22K
104.93%1.65M
-65.86%1.52M
-64.59%2.91M
48.38%2.02M
-76.71%806.42K
-5.69%4.44M
37.67%8.21M
-Accounts receivable
55.84%884.08M
41.13%826.48M
31.79%743.92M
10.75%598.22M
-10.43%567.28M
-6.46%585.6M
-72.55%564.45M
8.40%540.16M
18.96%633.35M
21.93%626.05M
Other receivables (including interest and dividends)
-2.00%73.77M
-10.11%70.67M
-31.77%58.76M
-22.35%51.72M
-30.45%75.28M
-1.46%78.62M
3.85%86.12M
2.95%66.6M
-1.57%108.23M
-24.98%79.79M
-Other receivable
----
-10.11%70.67M
----
----
----
-1.46%78.62M
----
2.95%66.6M
----
-24.98%79.79M
Contractual assets
----
----
----
----
----
----
----
----
--0
----
Advance payment
-41.50%16.3M
-34.38%21.36M
-33.97%26.11M
-35.01%17.26M
-45.89%27.87M
-55.64%32.54M
-68.92%39.55M
-50.40%26.56M
-13.65%51.5M
1.99%73.37M
Inventories
2.41%390.93M
-0.80%412.39M
-25.67%346.89M
-12.14%351.4M
-33.58%381.74M
-33.44%415.73M
-38.46%466.71M
3.55%399.97M
23.04%574.7M
25.44%624.62M
Receivable financing
----
----
----
----
----
----
----
----
--0
----
Assets held for sale
----
----
----
----
----
----
----
----
--0
----
Non-current assets due within one year
----
----
----
----
----
----
----
--200.26M
--0
----
Other current assets
1,358.34%274.96M
1,812.90%496.33M
2,868.37%693.45M
4,110.41%650.34M
81.39%18.85M
266.22%25.95M
277.53%23.36M
49.12%15.45M
-0.34%10.39M
-17.16%7.08M
Total current assets
19.07%3.76B
12.90%3.67B
25.99%4.05B
-3.49%3.23B
1.93%3.16B
-2.17%3.25B
-22.17%3.21B
29.58%3.35B
23.74%3.1B
18.79%3.32B
Non Current assets
Debt investment
161.86%554.81M
171.28%569.22M
-47.76%215.91M
-70.31%213.94M
-76.81%211.87M
-76.85%209.83M
-0.07%413.34M
75.01%720.48M
123.00%913.6M
122.35%906.51M
Other debt investment
----
----
----
----
----
----
----
----
--0
----
Other equity investment
-56.08%89.18M
-56.19%89.18M
-55.54%89.18M
-55.46%89.18M
-10.16%203.07M
-9.94%203.57M
-11.27%200.57M
-11.42%200.22M
20.42%226.04M
20.42%226.04M
Other non-current financial assets
----
----
----
----
----
----
----
----
--0
----
Investment real estate
----
----
----
----
----
----
----
----
--0
----
Long-term equity investment
13.26%443.24M
14.41%449.48M
25.05%453.62M
11.79%406.36M
12.65%391.34M
15.90%392.88M
9.08%362.74M
8.94%363.52M
2.24%347.39M
13.82%338.98M
Long term receivable account
----
----
----
----
----
----
----
----
--0
----
Fixed assets
----
2.28%999.66M
----
----
----
1.87%977.33M
----
13.16%963.8M
----
72.84%959.38M
Constru in process
----
21.22%359.74M
----
----
----
221.59%296.76M
----
1,116.01%199.14M
----
-52.31%92.28M
Productive biological assets
----
----
----
----
----
----
----
----
--0
----
Oil and gas assets
----
----
----
----
----
----
----
----
--0
----
Intangible assets
9.32%208.66M
-3.66%190.72M
-6.43%188.32M
-4.51%194.52M
-15.99%190.87M
-15.59%197.96M
-20.21%201.26M
-2.11%203.71M
26.24%227.21M
28.99%234.52M
Development expenditure
-22.49%54.07M
31.39%70.37M
31.37%65.65M
28.94%66.74M
25.31%69.75M
-2.32%53.55M
-8.53%49.98M
-4.31%51.76M
-35.69%55.66M
-14.75%54.83M
Goodwill
-3.43%111.42M
-3.43%111.42M
-3.43%111.42M
-3.43%111.42M
-27.23%115.37M
-27.23%115.37M
-5.21%115.37M
171.38%115.37M
227.66%158.54M
227.66%158.54M
Long deferred expense
34.28%16.71M
27.79%17.02M
51.81%18.23M
0.12%13.29M
-20.76%12.44M
-14.22%13.32M
-38.38%12.01M
-15.23%13.28M
-0.93%15.7M
7.90%15.53M
Deferred tax assets
39.45%70.4M
25.81%62.61M
4.06%59.93M
6.71%57.47M
-0.84%50.48M
-5.84%49.77M
-5.40%57.59M
25.93%53.86M
19.85%50.91M
102.55%52.85M
Usufruct assets
-55.36%22.28M
-6.85%51.86M
177.98%56.05M
70.64%45.01M
124.07%49.91M
125.30%55.68M
-31.51%20.16M
-30.54%26.38M
146.57%22.27M
235.46%24.71M
Other non current assets
50.76%43.18M
-18.39%24.72M
-34.29%18.95M
-16.69%32.83M
-5.12%28.64M
-1.44%30.3M
-68.06%28.84M
32.84%39.41M
-29.97%30.19M
-32.10%30.74M
Total non current assets
14.60%2.99B
15.39%3B
-2.93%2.62B
-13.98%2.54B
-17.78%2.61B
-16.11%2.6B
7.50%2.7B
29.98%2.95B
45.71%3.18B
52.50%3.09B
Total assets
17.05%6.75B
14.01%6.66B
12.78%6.67B
-8.40%5.77B
-8.05%5.77B
-8.89%5.85B
-10.94%5.92B
29.77%6.3B
33.97%6.27B
32.97%6.42B
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
-98.64%3M
1,094.70%204.36M
1,142.05%219.79M
1,374.35%221.05M
Transactional financial liabilities
----
----
----
-33.27%10.44M
--4.65M
--15.64M
--15.64M
--15.64M
----
----
Notes payable and accounts payable
3.49%137.44M
18.21%196.38M
-16.87%179.04M
-59.24%130.46M
-56.16%132.81M
-50.84%166.12M
-65.03%215.38M
-19.98%320.08M
-11.66%302.94M
-8.44%337.93M
-Notes payable
----
----
----
----
----
----
----
----
--0
----
-Accounts payable
3.49%137.44M
18.21%196.38M
-16.87%179.04M
-59.24%130.46M
-56.16%132.81M
-50.84%166.12M
-65.03%215.38M
-19.98%320.08M
-11.66%302.94M
-8.44%337.93M
Contract liabilities
-12.78%55.94M
-2.58%60.59M
-10.14%66.9M
-69.16%72.88M
-32.06%64.13M
-41.78%62.19M
-65.16%74.45M
193.38%236.31M
-21.37%94.38M
-45.98%106.81M
Advance receipts
----
----
----
----
----
----
----
----
--0
----
Salaries payable
23.41%53.06M
19.31%115.14M
18.18%86.71M
-8.33%151.05M
-67.09%42.99M
-52.38%96.51M
-44.25%73.37M
20.76%164.77M
160.93%130.64M
129.25%202.65M
Taxs payable
28.46%44.01M
28.66%51.84M
-23.17%52.55M
-56.80%37.37M
-71.91%34.26M
-75.07%40.29M
-60.21%68.39M
228.07%86.5M
237.39%121.98M
120.41%161.64M
Other payable (including interest and dividends)
345.25%208.73M
-20.37%43.23M
-15.21%48.77M
-29.99%61.58M
-55.58%46.88M
-63.33%54.29M
-76.42%57.52M
0.22%87.95M
4.34%105.52M
38.52%148.03M
-Other payable
----
-20.37%43.23M
----
----
----
-63.33%54.29M
----
0.22%87.95M
----
38.52%148.03M
Hold and for sell liabilities
----
----
----
----
----
----
----
----
--0
----
Non current liabilities due within one year
-77.15%4.94M
-4.18%21.7M
96.51%20.78M
12.73%19.01M
21.76%21.6M
-24.63%22.64M
-66.25%10.57M
-58.63%16.86M
21.34%17.74M
253.14%30.04M
Other current liabilities
18.69%652.74K
44.35%789.63K
-43.47%769.25K
-82.63%1.45M
-8.24%549.94K
-44.34%547.03K
153.88%1.36M
224.80%8.33M
--599.32K
524.54%982.83K
Total current liabilities
45.10%504.77M
6.86%489.66M
-12.35%455.51M
-57.56%484.23M
-64.99%347.88M
-62.10%458.23M
-68.10%519.67M
44.16%1.14B
45.55%993.6M
40.75%1.21B
Current liabilities
Long term loan
----
----
----
----
----
----
----
----
--0
----
Bonds payable
3.28%564.03M
3.82%566.34M
3.82%559.6M
3.82%552.84M
3.81%546.09M
4.34%545.5M
4.40%539.03M
4.27%532.49M
4.30%526.04M
4.56%522.8M
Long term salaries pay
----
----
----
----
----
----
----
----
--0
----
Estimate liabilities
----
----
----
----
----
----
----
----
--0
----
Deferred tax liabilities
-11.85%50.83M
-5.00%53.35M
-1.09%53.88M
-1.13%55.12M
17.31%57.67M
14.90%56.16M
87.05%54.47M
87.73%55.75M
130.46%49.16M
227.74%48.88M
Long term deferred income
11.72%45.73M
17.71%48.88M
-7.49%43.35M
61.12%37.21M
55.06%40.93M
12.09%41.52M
10.98%46.86M
145.70%23.1M
111.95%26.4M
188.47%37.05M
Lease liabilities
-39.89%18.06M
-2.36%33.69M
229.58%37.14M
147.53%27.69M
428.76%30.04M
799.35%34.51M
19.33%11.27M
7.30%11.19M
-37.11%5.68M
-47.91%3.84M
Other non current liabilities
----
----
----
----
----
----
----
----
--0
----
Total non current liabilities
0.58%678.65M
3.62%702.26M
6.50%693.97M
8.09%672.87M
11.11%674.73M
10.63%677.7M
9.13%651.62M
11.12%622.53M
10.99%607.27M
12.74%612.56M
Total liabilities
15.73%1.18B
4.93%1.19B
-1.86%1.15B
-34.39%1.16B
-36.12%1.02B
-37.64%1.14B
-47.39%1.17B
30.47%1.76B
30.17%1.6B
29.90%1.82B
Shareholders equity
Paid-in capital
8.30%481.42M
6.13%471.77M
6.18%471.97M
0.00%444.52M
0.00%444.52M
-0.07%444.51M
-0.07%444.51M
-0.10%444.51M
-0.10%444.51M
-0.03%444.83M
Other equity instruments
-0.03%107.45M
-0.01%107.49M
-0.01%107.49M
-0.01%107.49M
-0.02%107.49M
-0.01%107.5M
-0.07%107.5M
-0.10%107.5M
0.01%107.51M
-0.00%107.51M
Capital reserve funds
91.12%1.47B
83.68%1.42B
82.53%1.43B
-1.29%765.52M
-4.82%770.78M
-4.47%770.75M
-1.66%781.82M
-1.46%775.53M
0.61%809.77M
2.92%806.79M
Surplus reserve funds
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
0.00%261.06M
29.68%261.06M
29.68%261.06M
Retained profit
10.90%3.42B
10.65%3.34B
9.06%3.39B
9.18%3.17B
4.63%3.08B
4.62%3.02B
13.29%3.11B
57.85%2.9B
55.74%2.95B
58.45%2.89B
Less:Treasury stock
18.73%171.02M
3.75%118.21M
-15.79%132.46M
-15.79%132.46M
13.75%144.04M
-15.73%113.95M
15.54%157.3M
12.96%157.3M
-17.66%126.63M
28.64%135.21M
Other composite income
-1,106.83%-101.82M
-1,128.27%-100.86M
-1,320.94%-101.18M
-1,386.69%-101.59M
-83.81%10.11M
-82.51%9.81M
-84.52%8.29M
-84.69%7.9M
299.11%62.46M
262.73%56.09M
Ordinary risk reserve funds
----
----
----
----
----
----
----
----
--0
----
Specific reserves
----
----
----
----
----
----
----
----
--0
----
Shareholders equity without minority interests
20.66%5.47B
19.54%5.38B
19.09%5.42B
3.96%4.52B
0.62%4.53B
1.62%4.5B
6.67%4.55B
29.55%4.34B
36.01%4.51B
35.41%4.43B
Minority interests
-54.26%96.41M
-54.95%95.05M
-47.61%100.77M
-49.09%98.66M
27.64%210.78M
25.87%210.98M
28.93%192.34M
28.37%193.8M
18.91%165.14M
9.16%167.62M
Total shareholder equity
17.33%5.57B
16.20%5.47B
16.39%5.52B
1.69%4.61B
1.57%4.74B
2.51%4.71B
7.42%4.75B
29.50%4.54B
35.32%4.67B
34.23%4.59B
Total liabilityies and equity
17.05%6.75B
14.01%6.66B
12.78%6.67B
-8.40%5.77B
-8.05%5.77B
-8.89%5.85B
-10.94%5.92B
29.77%6.3B
33.97%6.27B
32.97%6.42B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -63.95%264.16M-62.27%393.56M56.27%1.17B-27.72%840.3M226.30%732.82M79.15%1.04B27.88%749M16.70%1.16B-75.46%224.58M-39.37%582.19M
Transactional financial assets 37.05%1.85B35.92%1.45B-21.28%1.01B-22.99%722.45M-9.30%1.35B-19.33%1.06B150.56%1.28B63.79%938.07M269.66%1.49B109.12%1.32B
Notes receivable and accounts receivable 55.88%886.66M40.50%826.87M31.36%744.11M10.89%599.87M-10.82%568.8M-7.21%588.51M-72.47%566.47M7.81%540.97M18.74%637.79M22.11%634.26M
-Notes receivable 69.98%2.58M-86.55%391.16K-90.32%195.22K104.93%1.65M-65.86%1.52M-64.59%2.91M48.38%2.02M-76.71%806.42K-5.69%4.44M37.67%8.21M
-Accounts receivable 55.84%884.08M41.13%826.48M31.79%743.92M10.75%598.22M-10.43%567.28M-6.46%585.6M-72.55%564.45M8.40%540.16M18.96%633.35M21.93%626.05M
Other receivables (including interest and dividends) -2.00%73.77M-10.11%70.67M-31.77%58.76M-22.35%51.72M-30.45%75.28M-1.46%78.62M3.85%86.12M2.95%66.6M-1.57%108.23M-24.98%79.79M
-Other receivable -----10.11%70.67M-------------1.46%78.62M----2.95%66.6M-----24.98%79.79M
Contractual assets ----------------------------------0----
Advance payment -41.50%16.3M-34.38%21.36M-33.97%26.11M-35.01%17.26M-45.89%27.87M-55.64%32.54M-68.92%39.55M-50.40%26.56M-13.65%51.5M1.99%73.37M
Inventories 2.41%390.93M-0.80%412.39M-25.67%346.89M-12.14%351.4M-33.58%381.74M-33.44%415.73M-38.46%466.71M3.55%399.97M23.04%574.7M25.44%624.62M
Receivable financing ----------------------------------0----
Assets held for sale ----------------------------------0----
Non-current assets due within one year ------------------------------200.26M--0----
Other current assets 1,358.34%274.96M1,812.90%496.33M2,868.37%693.45M4,110.41%650.34M81.39%18.85M266.22%25.95M277.53%23.36M49.12%15.45M-0.34%10.39M-17.16%7.08M
Total current assets 19.07%3.76B12.90%3.67B25.99%4.05B-3.49%3.23B1.93%3.16B-2.17%3.25B-22.17%3.21B29.58%3.35B23.74%3.1B18.79%3.32B
Non Current assets
Debt investment 161.86%554.81M171.28%569.22M-47.76%215.91M-70.31%213.94M-76.81%211.87M-76.85%209.83M-0.07%413.34M75.01%720.48M123.00%913.6M122.35%906.51M
Other debt investment ----------------------------------0----
Other equity investment -56.08%89.18M-56.19%89.18M-55.54%89.18M-55.46%89.18M-10.16%203.07M-9.94%203.57M-11.27%200.57M-11.42%200.22M20.42%226.04M20.42%226.04M
Other non-current financial assets ----------------------------------0----
Investment real estate ----------------------------------0----
Long-term equity investment 13.26%443.24M14.41%449.48M25.05%453.62M11.79%406.36M12.65%391.34M15.90%392.88M9.08%362.74M8.94%363.52M2.24%347.39M13.82%338.98M
Long term receivable account ----------------------------------0----
Fixed assets ----2.28%999.66M------------1.87%977.33M----13.16%963.8M----72.84%959.38M
Constru in process ----21.22%359.74M------------221.59%296.76M----1,116.01%199.14M-----52.31%92.28M
Productive biological assets ----------------------------------0----
Oil and gas assets ----------------------------------0----
Intangible assets 9.32%208.66M-3.66%190.72M-6.43%188.32M-4.51%194.52M-15.99%190.87M-15.59%197.96M-20.21%201.26M-2.11%203.71M26.24%227.21M28.99%234.52M
Development expenditure -22.49%54.07M31.39%70.37M31.37%65.65M28.94%66.74M25.31%69.75M-2.32%53.55M-8.53%49.98M-4.31%51.76M-35.69%55.66M-14.75%54.83M
Goodwill -3.43%111.42M-3.43%111.42M-3.43%111.42M-3.43%111.42M-27.23%115.37M-27.23%115.37M-5.21%115.37M171.38%115.37M227.66%158.54M227.66%158.54M
Long deferred expense 34.28%16.71M27.79%17.02M51.81%18.23M0.12%13.29M-20.76%12.44M-14.22%13.32M-38.38%12.01M-15.23%13.28M-0.93%15.7M7.90%15.53M
Deferred tax assets 39.45%70.4M25.81%62.61M4.06%59.93M6.71%57.47M-0.84%50.48M-5.84%49.77M-5.40%57.59M25.93%53.86M19.85%50.91M102.55%52.85M
Usufruct assets -55.36%22.28M-6.85%51.86M177.98%56.05M70.64%45.01M124.07%49.91M125.30%55.68M-31.51%20.16M-30.54%26.38M146.57%22.27M235.46%24.71M
Other non current assets 50.76%43.18M-18.39%24.72M-34.29%18.95M-16.69%32.83M-5.12%28.64M-1.44%30.3M-68.06%28.84M32.84%39.41M-29.97%30.19M-32.10%30.74M
Total non current assets 14.60%2.99B15.39%3B-2.93%2.62B-13.98%2.54B-17.78%2.61B-16.11%2.6B7.50%2.7B29.98%2.95B45.71%3.18B52.50%3.09B
Total assets 17.05%6.75B14.01%6.66B12.78%6.67B-8.40%5.77B-8.05%5.77B-8.89%5.85B-10.94%5.92B29.77%6.3B33.97%6.27B32.97%6.42B
Liabilities
Current liabilities
Short term loan -------------------------98.64%3M1,094.70%204.36M1,142.05%219.79M1,374.35%221.05M
Transactional financial liabilities -------------33.27%10.44M--4.65M--15.64M--15.64M--15.64M--------
Notes payable and accounts payable 3.49%137.44M18.21%196.38M-16.87%179.04M-59.24%130.46M-56.16%132.81M-50.84%166.12M-65.03%215.38M-19.98%320.08M-11.66%302.94M-8.44%337.93M
-Notes payable ----------------------------------0----
-Accounts payable 3.49%137.44M18.21%196.38M-16.87%179.04M-59.24%130.46M-56.16%132.81M-50.84%166.12M-65.03%215.38M-19.98%320.08M-11.66%302.94M-8.44%337.93M
Contract liabilities -12.78%55.94M-2.58%60.59M-10.14%66.9M-69.16%72.88M-32.06%64.13M-41.78%62.19M-65.16%74.45M193.38%236.31M-21.37%94.38M-45.98%106.81M
Advance receipts ----------------------------------0----
Salaries payable 23.41%53.06M19.31%115.14M18.18%86.71M-8.33%151.05M-67.09%42.99M-52.38%96.51M-44.25%73.37M20.76%164.77M160.93%130.64M129.25%202.65M
Taxs payable 28.46%44.01M28.66%51.84M-23.17%52.55M-56.80%37.37M-71.91%34.26M-75.07%40.29M-60.21%68.39M228.07%86.5M237.39%121.98M120.41%161.64M
Other payable (including interest and dividends) 345.25%208.73M-20.37%43.23M-15.21%48.77M-29.99%61.58M-55.58%46.88M-63.33%54.29M-76.42%57.52M0.22%87.95M4.34%105.52M38.52%148.03M
-Other payable -----20.37%43.23M-------------63.33%54.29M----0.22%87.95M----38.52%148.03M
Hold and for sell liabilities ----------------------------------0----
Non current liabilities due within one year -77.15%4.94M-4.18%21.7M96.51%20.78M12.73%19.01M21.76%21.6M-24.63%22.64M-66.25%10.57M-58.63%16.86M21.34%17.74M253.14%30.04M
Other current liabilities 18.69%652.74K44.35%789.63K-43.47%769.25K-82.63%1.45M-8.24%549.94K-44.34%547.03K153.88%1.36M224.80%8.33M--599.32K524.54%982.83K
Total current liabilities 45.10%504.77M6.86%489.66M-12.35%455.51M-57.56%484.23M-64.99%347.88M-62.10%458.23M-68.10%519.67M44.16%1.14B45.55%993.6M40.75%1.21B
Current liabilities
Long term loan ----------------------------------0----
Bonds payable 3.28%564.03M3.82%566.34M3.82%559.6M3.82%552.84M3.81%546.09M4.34%545.5M4.40%539.03M4.27%532.49M4.30%526.04M4.56%522.8M
Long term salaries pay ----------------------------------0----
Estimate liabilities ----------------------------------0----
Deferred tax liabilities -11.85%50.83M-5.00%53.35M-1.09%53.88M-1.13%55.12M17.31%57.67M14.90%56.16M87.05%54.47M87.73%55.75M130.46%49.16M227.74%48.88M
Long term deferred income 11.72%45.73M17.71%48.88M-7.49%43.35M61.12%37.21M55.06%40.93M12.09%41.52M10.98%46.86M145.70%23.1M111.95%26.4M188.47%37.05M
Lease liabilities -39.89%18.06M-2.36%33.69M229.58%37.14M147.53%27.69M428.76%30.04M799.35%34.51M19.33%11.27M7.30%11.19M-37.11%5.68M-47.91%3.84M
Other non current liabilities ----------------------------------0----
Total non current liabilities 0.58%678.65M3.62%702.26M6.50%693.97M8.09%672.87M11.11%674.73M10.63%677.7M9.13%651.62M11.12%622.53M10.99%607.27M12.74%612.56M
Total liabilities 15.73%1.18B4.93%1.19B-1.86%1.15B-34.39%1.16B-36.12%1.02B-37.64%1.14B-47.39%1.17B30.47%1.76B30.17%1.6B29.90%1.82B
Shareholders equity
Paid-in capital 8.30%481.42M6.13%471.77M6.18%471.97M0.00%444.52M0.00%444.52M-0.07%444.51M-0.07%444.51M-0.10%444.51M-0.10%444.51M-0.03%444.83M
Other equity instruments -0.03%107.45M-0.01%107.49M-0.01%107.49M-0.01%107.49M-0.02%107.49M-0.01%107.5M-0.07%107.5M-0.10%107.5M0.01%107.51M-0.00%107.51M
Capital reserve funds 91.12%1.47B83.68%1.42B82.53%1.43B-1.29%765.52M-4.82%770.78M-4.47%770.75M-1.66%781.82M-1.46%775.53M0.61%809.77M2.92%806.79M
Surplus reserve funds 0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M0.00%261.06M29.68%261.06M29.68%261.06M
Retained profit 10.90%3.42B10.65%3.34B9.06%3.39B9.18%3.17B4.63%3.08B4.62%3.02B13.29%3.11B57.85%2.9B55.74%2.95B58.45%2.89B
Less:Treasury stock 18.73%171.02M3.75%118.21M-15.79%132.46M-15.79%132.46M13.75%144.04M-15.73%113.95M15.54%157.3M12.96%157.3M-17.66%126.63M28.64%135.21M
Other composite income -1,106.83%-101.82M-1,128.27%-100.86M-1,320.94%-101.18M-1,386.69%-101.59M-83.81%10.11M-82.51%9.81M-84.52%8.29M-84.69%7.9M299.11%62.46M262.73%56.09M
Ordinary risk reserve funds ----------------------------------0----
Specific reserves ----------------------------------0----
Shareholders equity without minority interests 20.66%5.47B19.54%5.38B19.09%5.42B3.96%4.52B0.62%4.53B1.62%4.5B6.67%4.55B29.55%4.34B36.01%4.51B35.41%4.43B
Minority interests -54.26%96.41M-54.95%95.05M-47.61%100.77M-49.09%98.66M27.64%210.78M25.87%210.98M28.93%192.34M28.37%193.8M18.91%165.14M9.16%167.62M
Total shareholder equity 17.33%5.57B16.20%5.47B16.39%5.52B1.69%4.61B1.57%4.74B2.51%4.71B7.42%4.75B29.50%4.54B35.32%4.67B34.23%4.59B
Total liabilityies and equity 17.05%6.75B14.01%6.66B12.78%6.67B-8.40%5.77B-8.05%5.77B-8.89%5.85B-10.94%5.92B29.77%6.3B33.97%6.27B32.97%6.42B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data